Telehealth platforms, compounding pharmacies, and in-person clinics — each entry is a real, operating provider with a public website. “Verified” means we confirmed the entity is a licensed operator, not a quality rating. Pricing is shown only when the clinic posts it.
One-year metabolic-health program combining GLP-1 prescribing (when medically indicated) with curriculum-driven coaching.
Texas-licensed 503A and FDA-registered 503B outsourcing facility. One of the larger compounders of peptide-based therapies; does not prescribe — works with licensed providers.
Obesity-medicine telehealth with clinician-led care. Protocols include GLP-1s, metformin, bupropion/naltrexone, and other weight-management medications based on clinical fit.
Subscription telehealth offering weight-loss, hormone, and other treatment tracks. Publishes flat monthly pricing that includes consult and medication.
Publicly-traded telehealth company (NYSE: HIMS). Weight-loss track includes branded and compounded GLP-1s via its affiliated pharmacies, subject to FDA shortage rules.
GLP-1-focused telehealth clinic. Offers branded and compounded semaglutide/tirzepatide with dietitian-led support.
Clinical arm of the Noom behavior-change platform. Prescribes GLP-1s where indicated alongside the core Noom program.
Direct-to-consumer telehealth platform. Weight-management program offers branded GLP-1s (Wegovy, Zepbound) via its connected pharmacies as well as compounded formulations during FDA shortage windows.
Kentucky-based 503A compounding pharmacy with nationwide shipping. Focuses on peptide and hormone compounds; prescription required.
Telehealth arm of WW International (NASDAQ: WW), built on the Sequence acquisition. Prescribes GLP-1 medications for eligible members as part of the WW weight-health programs.